Proquility Private Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Proquility Private Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,991	Closed	-$1.04M	–	90
2023 Q3	$1.04M	Sell	17,991 -623	-3%	-$38.2K	0.43%	63
2023 Q2	$1.19M	Buy	18,614 +30	+0.2%	+$2.01K	0.47%	62
2023 Q1	$1.29M	Sell	18,584 -14,934	-45%	-$1.05M	0.51%	59
2022 Q4	$2.41M	Buy	33,518 +58	+0.2%	+$4.37K	0.99%	34
2022 Q3	$2.38M	Sell	33,460 -469	-1%	-$34K	1.09%	31
2022 Q2	$2.61M	Sell	33,929 -180	-0.5%	-$13.7K	1.12%	28
2022 Q1	$2.6M	Buy	34,109 +7,151	+27%	+$480K	1.09%	30
2021 Q4	$1.79M	Sell	26,958 -6,374	-19%	-$374K	0.63%	55
2021 Q3	$1.97M	Buy	33,332 +905	+3%	+$59.6K	0.75%	52
2021 Q2	$2.17M	Sell	32,427 -7,127	-18%	-$465K	0.81%	46
2021 Q1	$2.5M	Buy	39,554 +16,942	+75%	+$1.05M	1%	34
2020 Q4	$1.4M	Buy	+22,612	New	+$1.39M	0.64%	45

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Proquility Private Wealth Partners's BMY Position: Q4 2023 in Review

Proquility Private Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 17,991 shares — an estimated $1.04M sold.

Proquility Private Wealth Partners first reported a position in BMY in Q4 2020 and held it in 12 quarters. The position peaked at $2.61M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Proquility Private Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Proquility Private Wealth Partners sold 17,991 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.04M.
Proquility Private Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 12 quarters.
Proquility Private Wealth Partners's Bristol-Myers Squibb position peaked at $2.61M in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Proquility Private Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.